HIV Exposure but Not Early CMV Infection is Associated with Increased Hospitalization and Decreased Memory T-cell Responses to Tetanus Vaccine.
HIV-exposed, uninfected (HEU) infants experience high rates of infectious morbidity. We hypothesized that early CMV infection was associated with increased hospitalization rates and decreased vaccine responses in HEU compared with HIV-unexposed (HUU) infants. Among infants enrolled in the Tshipidi study in Botswana, we determined CMV infection status by 6 months of age and compared hospitalization rates and responses to tetanus and BCG vaccines among HEU and HUU vaccinees. Fifteen of 226 (6.6%) HEU infants and 17 (19.3%) of 88 HUU infants were CMV-infected by 6 months. HEU infants were nearly 3 times as likely to be hospitalized compared with HUU infants (p=0.02). HEU peripheral blood cells produced less IL-2 (p=0.004), but similar amounts of IFNγ, following stimulation with tetanus toxoid. Anti-tetanus IgG titers were similar between groups. Cellular responses to PPD stimulation did not differ between groups. Maternal receipt of 3-drug antiretroviral therapy compared with zidovudine was associated with increased IL-2 expression after tetanus toxoid stimulation. CMV infection status was not associated with clinical or vaccine response outcomes. We observed that increased rates of hospitalization and decreased memory T cell responses to tetanus vaccine were associated with HIV exposure and incomplete treatment of maternal HIV infection, but not early CMV infection.